Plasminogen Activator Inhibitor-1 (PAI-1) Genotypi

What is the role of the plasminogen activator inhibitor (PAI-1) test?

The PAI-1 test measures the level of plasminogen activator inhibitor-1 in the blood. PAI-1 is a protein that regulates blood clot formation by inhibiting tissue plasminogen activator (tPA). Abnormal PAI-1 levels are associated with an increased risk of thrombosis and cardiovascular disease.


When is the PAI-1 test recommended?

The test is recommended for individuals with a personal or family history of thrombosis, recurrent miscarriages, or unexplained cardiovascular events. It is also used to assess clotting disorders and monitor patients undergoing fibrinolytic therapy.


How is the PAI-1 test performed?

A blood sample is collected, and PAI-1 levels are measured using immunoassay techniques. The results help determine whether abnormal levels of PAI-1 are contributing to an increased risk of clot formation or impaired fibrinolysis.


What do abnormal PAI-1 levels indicate?

Elevated PAI-1 levels indicate a higher risk of clot formation, potentially leading to thrombotic events such as deep vein thrombosis (DVT) and myocardial infarction. Low PAI-1 levels may increase the risk of excessive bleeding due to impaired clot formation.


How are abnormal PAI-1 levels managed?

Management strategies may include anticoagulant therapy, lifestyle modifications, and addressing underlying conditions that may contribute to abnormal PAI-1 levels. Regular monitoring is essential for individuals at high risk of thrombotic events.